Elizabeth Budde, M.D., Ph.D. is a distinguished expert in the field of hematology, specializing in treatment and research of blood malignancies. Her scholarly and clinical pursuits are dedicated to developing innovative therapies for patients battling lymphoma and leukemia. In her dual role as a physician scientist, she directs a dedicated research team in her laboratory, that designs immunotherapeutic treatments and conducts bench to bedside translation.

Dr. Budde has authored a multitude of articles in leading scientific journals such as Nature Medicine, Lancet Oncology, Journal of Clinical Oncology, Blood, Journal of Hematology & Oncology, and Clinical Cancer Research. Her work has merited her invitations to speak at various national and international conferences. As the lead investigator for several cutting-edge translational research studies, Dr. Budde actively manages a diverse array of clinical trials. She is passionately committed to extending access to the latest medical advancements to her patients, ensuring they receive the most forward-thinking care available.